These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15343564)

  • 1. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation.
    Blankenship JC; Islam MA; Wood GC; Iliadis EA
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):31-41. PubMed ID: 15343564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invisible showers.
    Topol EJ
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):42-3. PubMed ID: 15343565
    [No Abstract]   [Full Text] [Related]  

  • 3. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
    Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy).
    Blankenship JC; Haldis T; Feit F; Hu T; Kleiman NS; Topol EJ; Lincoff AM;
    Am J Cardiol; 2006 Jun; 97(11):1591-6. PubMed ID: 16728220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial.
    Blankenship JC; Sigmon KN; Pieper KS; O'Shea C; Tardiff BE; Tcheng JE;
    Am J Cardiol; 2001 Nov; 88(9):969-73. PubMed ID: 11703991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.
    Blankenship JC; Tasissa G; O'Shea JC; Iliadis EA; Bachour FA; Cohen DJ; Lui HK; Mann T; Cohen E; Tcheng JE;
    J Am Coll Cardiol; 2001 Sep; 38(3):653-8. PubMed ID: 11527612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention.
    Cai Q; Skelding KA; Armstrong AT; Desai D; Wood GC; Blankenship JC
    Am J Cardiol; 2007 Mar; 99(5):616-20. PubMed ID: 17317359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.
    Ricciardi MJ; Wu E; Davidson CJ; Choi KM; Klocke FJ; Bonow RO; Judd RM; Kim RJ
    Circulation; 2001 Jun; 103(23):2780-3. PubMed ID: 11401931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of Shin's method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: an intravascular ultrasound study.
    Shin ES; Garcia-Garcia HM; Garg S; Park J; Kim SJ; Serruys PW
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):883-92. PubMed ID: 20972833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
    Domanski M; Farkouh ME; Zak V; French J; Alexander JH; Bochenek A; Hamon M; Mahaffey K; Puskas J; Smith P; Shrader P; Fuster V
    Am J Cardiol; 2016 Dec; 118(11):1655-1660. PubMed ID: 27816118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation.
    Yonetsu T; Kakuta T; Lee T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    Int J Cardiol; 2011 Jan; 146(1):80-5. PubMed ID: 20591515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention.
    Kanaparti PK; Brown DL
    Am J Cardiol; 2000 Sep; 86(6):619-22. PubMed ID: 10980211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.